Scandinavian Distributor of Medical Diagnostic and Life Science Products

Cancer Markers

Oral Cancer Screening Test


OncAlert™ Point-of-Care Test
OncAlert™ Laboratory Test


OncAlert™ is a new rapid oral rinse test for early screening and risk assessment of Head and Neck Squamous Cell Carcinoma (HNSCC). The test can be performed at the dentist 19s office or the physician 19s office for routine screening of patients who are at risk of developing oral and  head/neck cancer. Increased risk is associated with alcohol and tobacco use. Early detection of oral cancer before visual symptoms means early intervention and better overall outcome. OncAlert™ rapid test also exists as a quantitative laboratory ELISA assay.







Early Detection Before Visual Symptoms

  • Oral rinse test
  • Early Detection
  • High specificity & sensitivity
  • Simple-to-use
  • Results within 10 minutes
  • Semi-quantitative result
  • Affordable
  • Non-invasive 

For more information download the OncAlert information brochure



Colorectal Cancer Screening


M2-PK Quick™ stool test




The immunochromatographic rapid test detects M2-PK (M2-pyruvate kinase) in stool samples. The test is specific for colorectal cancer because it does not measure blood in the stool but instead it recognizes the enzyme M2-PK.The test result is not affected by any foods, so no dietary restrictions are necessary before taking the stool sample.

Key Advantages:

  • High sensitivity & specificity
  • Not dependent on FOB
  • Detects bleeding or non-bleeding bowel polyps
  • Detects bleeding or non-bleeding bowel tumours
  • Not affected by specific foods & no special diet required
  • No false results from haemorrhoids or other sources of blood in the bowel
  • Requires small sample volume


For more information download the M2-PK Quick information brochure




2 in 1 Quick™ stool test




This is an improved colorectal cancer-screening test. The immunochromatographic rapid test detects both M2-PK (M2-pyruvate kinase) and FOB (feacal occult blood) in stool samples. The test detects colorectal cancers and polyps by simultaneously using direct (M2-PK) and indirect methods (iFOBT).


For more information download the 2 in1 Quick information brochure



Pancreas Elastase 1 Quick™ stool test




Stool test for exocrine pancreatic function. Allows for the diagnosis or exclusion of pancreatic exocrine insufficiency, which can be caused by chronic pancreatitis, cystic fibrosis, pancreatic tumor, cholelithiasis or diabetes mellitus for example.  


Advantages:

  • Requires small stool sample
  • Test results available within minutes
  • High sensitivity and specificity
  • Easy-to-perform
  • Pancreatic Elastase 1 is stable during intestinal transit
  • Absolutely pancreas specific
  • Uses monoclonal antibodies
  • Enzyme therapy does not affect the test result
  • Not affected by foodstuffs
  • No special diet required

For more information download the Pancreas Elastase 1 Quick information brochure



Product Description Product Code
OncAlert POC Test VB-0001 Enquiry
OncAlert LAB Assay VB-0002 Enquiry
M2-PK Quick Stool Test
SB-0001 Enquiry
2 in 1 Quick Stool Test
SB-0002 Enquiry
Pancreas Elastase 1 Quick Stool Test SB-0003 Enquiry